AstraZeneca Bolsters Pipeline with Neogene Therapeutics and C4X Discovery Deals
By Lucy Haggerty & Amit Kaushik
Pharma Deals Review: Vol 2022 Issue 12 (Table of Contents)
Published: 9 Dec-2022
DOI: 10.3833/pdr.v2022.i12.2752 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Hoping to enter the cell therapy space, AstraZeneca has agreed to acquire Neogene Therapeutics in a deal worth up to US$320 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS